Omitting the 5-fluorouracil (5-FU) bolus from multidrug regimens in patients with advanced gastrointestinal cancers reduces toxicities, such as cytopenia, and does not affect overall survival. Initial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback